Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of the Effect of AVE0657 in Cheynes-Stokes Breathing Syndrome Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 5.0

Eligibility Criteria:
Inclusion Criteria:~* Presence of Congestive heart failure (CHF) defined as ejection fraction ≤40% by history of echocardiography data and New York heart Association (NYHA) class II-III and of typical cyclic crescendo and decrescendo change in breathing amplitude AHI ≥10 and \<60 and majority of the apneas to be ≥60% central in origin.~Exclusion Criteria:~* Subject on supplemental oxygen~The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Dose Level 1 (Type: EXPERIMENTAL): None
- Dose Level 2 (Type: EXPERIMENTAL): None
- Dose Level 3 (Type: EXPERIMENTAL): None
- Dose Level 4 (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): 12 subjects: 3 subjects per dose level

Based on this trial design, predict the completion outcome and termination type (if applicable).